The Memphis Grizzlies will be without their top player for the remainder of the campaign as it was announced on Tuesday that Ja Morant will undergo a procedure for his elbow injury.
Morant was limited to only 20 games this season due to his elbow injury and other ailments. The Grizzlies said that while the athletic guard was making good progressThey have decided to err on the side of caution.
"After a recent consultation to advise on prolonged discomfort, it was recommended that Morant receive PRP (platelet-rich plasma) injections to further optimize ligament healing. Morant will begin to wear the elbow following the injection and will miss the remainder of the 2025-26 season, but is expected to make a full recovery before the 2026-27 season," the team statement said.
@memgrizz The following medical updates were announced today for Ja Morant, Brandon Clarke and Zach Eddy: pic.twitter.com/gV8rLPlwbs
- Grizzlies PR (@GrizzliesPR) 25 March 2026
The Grizzlies are likely to miss the playoffs with a 24-47 record, and they probably don't see any benefit in playing the 26-year-old Morant at this point. They are 1-11 in their last 12 assignments.
Many thought Memphis would part ways with Morant at the trade deadline. However, despite numerous controversies, no deal was made, keeping him with the Grizzlies.
He averaged 19.5 points, 3.2 rebounds and 8.1 assists this season.
Over the past three campaigns, Morant has played in just 79 games combined.
Even without him, the Grizzlies are currently stacked in the backcourt, with Ty Jerome, Jaylen Wells, Walter Clayton Jr., Cam Spencer, Javon Small and Jahmai Mashek splitting minutes.
Memphis was defeated by the Atlanta Hawks 146-107 on Monday and will return to action on Wednesday against the San Antonio Spurs.
